BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 6140867)

  • 1. Poor outcome and low platelet MAO activity in chronic schizophrenia.
    Bierer L; Docherty JP; Young JG; Giller E; Cohen D
    Am J Psychiatry; 1984 Feb; 141(2):257-60. PubMed ID: 6140867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet monoamine oxidase in chronic schizophrenic patients.
    Berger PA; Ginsburg RA; Barchas JD; Murphy DL; Wyatt RJ
    Am J Psychiatry; 1978 Jan; 135(1):95-9. PubMed ID: 618534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet MAO activity in schizophrenia and other psychiatric illnesses.
    Sullivan J; Stanfield CN; Dackis C
    Am J Psychiatry; 1977 Oct; 134(10):1098-1103. PubMed ID: 900261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet glutathione peroxidase and monoamine oxidase activity in schizophrenics with CT scan abnormalities: relation to psychosocial variables.
    Buckman TD; Kling A; Sutphin MS; Steinberg A; Eiduson S
    Psychiatry Res; 1990 Jan; 31(1):1-14. PubMed ID: 1969170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human platelet MAO in drug-free and medicated schizophrenic patients.
    Friedhoff AJ; Miller JC; Weisenfreund J
    Am J Psychiatry; 1978 Aug; 135(8):952-5. PubMed ID: 27104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary trace amine excretion and platelet monoamine oxidase activity in schizophrenia.
    Yoshimoto S; Kaku H; Shimogawa S; Watanabe A; Nakagawara M; Takahashi R
    Psychiatry Res; 1987 Jul; 21(3):229-36. PubMed ID: 3628609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary tryptamine excretion in chronic schizophrenics with low platelet MAO activity.
    Sullivan JL; Coffey CE; Basuk B; Cavenar JO; Maltbie AA; Zung WW
    Biol Psychiatry; 1980 Feb; 15(1):113-20. PubMed ID: 7357050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoamine oxidase activity and enzyme kinetics in three subpopulations of density-fractionated platelets in chronic paranoid schizophrenics.
    Mann JJ; Kaplan RD; Georgotas A; Friedman E; Branchey M; Gershon S
    Psychopharmacology (Berl); 1981; 74(4):344-8. PubMed ID: 6794079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet monoamine oxidase response to lithium treatment in psychiatric patients.
    Huang LG; Bowden CL
    J Clin Psychopharmacol; 1984 Dec; 4(6):326-31. PubMed ID: 6512000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet monoamine oxidase: studies on the rate of heat inactivation in normal and in paranoid and nonparanoid chronic schizophrenic groups.
    Wise CD; Bridge TP; Potkin SG; Wyatt RJ
    Psychiatry Res; 1979 Oct; 1(2):187-90. PubMed ID: 298348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet MAO activity and long-term outcome in schizophrenia and schizoaffective disorder.
    Malas KL; van Kammen DP
    Am J Psychiatry; 1983 Jun; 140(6):794-6. PubMed ID: 6846644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet monoamine oxidase activity in acute schizophrenia.
    Carpenter WT; Murphy DL; Wyatt RJ
    Am J Psychiatry; 1975 Apr; 132(4):438-41. PubMed ID: 1119597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet monoamine oxidase in schizophrenia: a meta-analysis.
    Marcolin MA; Davis JM
    Schizophr Res; 1992 Sep; 7(3):249-67. PubMed ID: 1356426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet monoamine-oxidase activity in schizophrenia. Relation to genetic load of the illness and treatment with antipsychotic drugs.
    Kemali D; Maj M; Ariano MG; Salvati A
    Encephale; 1985; 11(1):31-4. PubMed ID: 2859981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Some kinetic parameters of platelet monoamine oxidase in chronic schizophrenia.
    Kobes RD; Potkin SG; Wise CD; Bridge TP; Neckers LM; Wyatt RJ
    Psychiatry Res; 1979 Oct; 1(2):179-85. PubMed ID: 298347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced platelet monoamine oxidase activity in a subgroup of schizophrenic patients.
    Schildkraut JJ; Herzog JM; Orsulak PJ; Edelman SE; Shein HM; Frazier SH
    Am J Psychiatry; 1976 Apr; 133(4):438-40. PubMed ID: 1267046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet monoamine oxidase activity in subgroups of schizophrenic disorders.
    Schildkraut JJ; Orsulak PJ; Schatzberg AF; Herzog JM
    Schizophr Bull; 1980; 6(2):220-5. PubMed ID: 7375853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet monoamine oxidase activity in schizophrenic patients.
    Becker RE; Shaskan EG
    Am J Psychiatry; 1977 May; 134(5):512-7. PubMed ID: 848577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet monoamine oxidase and clinical phenomenology of schizophrenia.
    Baron M; Gruen R; Levitt M; Kane J
    Psychiatry Res; 1984 Mar; 11(3):205-9. PubMed ID: 6587413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in platelet monoamine oxidase activity in subgroups of schizophrenic and depressive disorders.
    Orsulak PJ; Schildkraut JJ; Schatzberg AF; Herzog JM
    Biol Psychiatry; 1978 Dec; 13(6):637-47. PubMed ID: 737252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.